RecruitingNCT05102799
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants
Studying Anoctamin-5-related limb-girdle muscular dystrophy R12
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rigshospitalet, Denmark
- Intervention
- No intervention(other)
- Enrollment
- 200 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Nanna Scharff Poulsen, Copenhagen, Denmark
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05102799 on ClinicalTrials.govOther trials for Anoctamin-5-related limb-girdle muscular dystrophy R12
Additional recruiting or active studies for the same condition.
See all trials for Anoctamin-5-related limb-girdle muscular dystrophy R12 →